Abstract:Pathological disruption of Nucleocytoplasmic Transport (NCT), such as the mis-localization of nuclear pore complex proteins (Nups), nuclear transport receptors, Ran-GTPase, and RanGAP1, are seen in both animal models and in familial and sporadic forms of amyotrophic lateral sclerosis (ALS), frontal temporal dementia and frontal temporal lobar degeneration (FTD\FTLD), and Alzheimer's and Alzheimer's Related Dementias (AD/ADRD). However, the question of whether these alterations represent a primary cause, or a downstream consequence of disease is unclear, and what upstream factors may account for these defects are unknown. Here, we report four key findings that shed light on the upstream causal role of Importin-β-specific nuclear transport defects in disease onset. First, taking advantage of two novel mouse models of NEMF neurodegeneration (NemfR86S and NemfR487G) that recapitulate many cellular and biochemical aspects of neurodegenerative diseases, we find an Importin-β-specific nuclear import block. Second, we observe cytoplasmic mis-localization and aggregation of multiple proteins implicated in the pathogenesis of ALS/FTD and AD/ADRD, including TDP43, Importin-β, RanGap1, and Ran. These findings are further supported by a pathological interaction between Importin-β and the mutant NEMFR86S protein in cytoplasmic accumulations. Third, we identify similar transcriptional dysregulation in key genes associated with neurodegenerative disease. Lastly, we show that even transient pharmaceutical inhibition of Importin-β in both mouse and human neuronal and non-neuronal cells induces key proteinopathies and transcriptional alterations seen in our mouse models and in neurodegeneration. Our convergent results between mouse and human neuronal and non-neuronal cellular biology provide mechanistic evidence that many of the mis-localized proteins and dysregulated transcriptional events seen in multiple neurodegenerative diseases may in fact arise primarily from a primary upstream defect in Importin- β nuclear import. These findings have critical implications for investigating how sporadic forms of neurodegeneration may arise from presently unidentified genetic and environmental perturbations in Importin-β function.

Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration

Research Progress on Vesicular Trafficking in Amyotrophic Lateral Sclerosis.

Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review

Nuclear pore dysfunction and disease: a complex opportunity

Regulation of neuronal autophagy and the implications in neurodegenerative diseases

Importin-β specific nuclear transport defects recapitulate phenotypic and transcriptional alterations seen in neurodegeneration

Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors

Disruption of axonal transport in neurodegeneration

Nuclear and degradative functions of the ESCRT-III pathway: implications for neurodegenerative disease

Dysregulation of Protein Trafficking in Neurodegeneration

Nuclear Transport Receptor,Importin β Family Proteins,and the Regulation Mechanisms in Nucleocytoplasmic Transport

Altered nuclear envelope homeostasis is a key pathogenic event in C9ORF72-linked ALS/FTD

Regulation of Mitochondrial Transport in Neurons.

The mechanisms of Ca2+ regulating autophagy and its research progress in neurodegenerative diseases: A review

NEMF mutations in mice illustrate how Importin-β specific nuclear transport defects recapitulate neurodegenerative disease hallmarks

Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS

Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways

Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and Therapy

Role of Dynein and Dynactin (DCTN-1) in Neurodegenerative Diseases

Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD

Nuclear envelope dysfunction and its contribution to the aging process